{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:10:08Z","timestamp":1752156608860,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>We present the case of a 40-year-old man who developed severe acute respiratory failure along with hemoptysis and was subsequently diagnosed with granulomatosis with polyangiitis (GPA). He was initially treated with high-dose corticosteroids, cyclophosphamide, plasmapheresis, and mechanical ventilation (MV). The patient\u2019s condition deteriorated after being weaned from MV, leading to his transfer to our medical center without reintubation. Upon admission, a high-flow nasal cannula delivering FiO2 of 1.0 was immediately initiated. Despite the severity of hypoxemia, the patient exhibited neither tachypnea nor subjective dyspnea, and was subsequently initiated on \u201cawake\u201d venovenous extracorporeal membrane oxygenation (VV-ECMO) without MV. Anticoagulation therapy was initiated, and continuous renal replacement therapy was commenced to manage anuria associated with acute renal failure. Due to treatment failure after initial immunosuppressive therapy with cyclophosphamide, rituximab was administered as an induction agent. Following four cycles of rituximab, the patient\u2019s respiratory function showed marked improvement. Subsequently, a splenic artery hemorrhage occurred but was effectively managed through prompt embolization, resulting in immediate hemodynamic stabilization. The patient was successfully weaned off VV-ECMO support on day 22 after starting ECMO. After the transfer from the intensive care unit, the patient began active rehabilitation, during which he reported episodes of dizziness. Magnetic resonance imaging of the brain revealed multiple acute infarctions, which are presumed to be caused by vasculitis, leading to the initiation of adjunctive antiplatelet therapy. This represents the first reported case of refractory severe GPA affecting the kidneys, splenic artery, and central nervous system and resulting in respiratory failure, which was managed using \u201cawake\u201d VV-ECMO. The patient remains on maintenance hemodialysis and continues treatment with corticosteroids and rituximab. No disease relapse has occurred until now (June 2025), and the patient is undergoing rehabilitation for intensive care unit-acquired weakness.<\/jats:p>","DOI":"10.3389\/fmed.2025.1461269","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T05:46:51Z","timestamp":1752126411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Rescue \u201cawake\u201d extracorporeal membrane oxygenation for acute respiratory failure in severe granulomatosis with polyangiitis with multisystem involvement"],"prefix":"10.3389","volume":"12","author":[{"given":"Taehun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong Chan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.7759\/cureus.29909","article-title":"Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage: a systematic review","author":"Da Silva","year":"2022","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40560-022-00615-6","article-title":"ARDS clinical practice guideline 2021","volume":"10","author":"Tasaka","year":"2022","journal-title":"J Intensive Care"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-016-1329-y","article-title":"\u201cAwake\u201d extracorporeal membrane oxygenation (ECMO): pathophysiology, technical considerations, and clinical pioneering","volume":"20","author":"Langer","year":"2016","journal-title":"Crit Care"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.21037\/atm-21-3133","article-title":"A novel therapeutic strategy using extracorporeal membrane oxygenation in patients with anti-neutrophil cytoplasmic antibodies-associated vasculitis: a case report and literature review","volume":"9","author":"Wang","year":"2021","journal-title":"Ann Transl Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"671396","DOI":"10.3389\/fmed.2021.671396","article-title":"Ecmo rescues patients with acute respiratory failure related to GpA","volume":"8","author":"Wan","year":"2021","journal-title":"Front Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/jocs.15252","article-title":"Extracorporeal membrane oxygenation in the management of granulomatosis with polyangiitis","volume":"36","author":"Yin","year":"2021","journal-title":"J Card Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00296-018-4116-z","article-title":"The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature","volume":"39","author":"Delvino","year":"2019","journal-title":"Rheumatol Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"OD10-1","DOI":"10.7860\/JCDR\/2016\/20649.7969","article-title":"ECMO rescue therapy in diffuse alveolar haemorrhage: a case report with review of literature","volume":"10","author":"Rawal","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12969-022-00693-8","article-title":"The use of ECMO in pediatric granulomatosis with polyangiitis","volume":"20","author":"Finkel","year":"2022","journal-title":"Pediatr Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/art.41986","article-title":"2022 American College of Rheumatology\/European Alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis","volume":"74","author":"Robson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0049-0172(97)80013-3","article-title":"Splenic involvement in rheumatic diseases","volume":"27","author":"Fishman","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s10067-019-04568-4","article-title":"Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes","volume":"38","author":"Katikineni","year":"2019","journal-title":"Clin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/art.11075","article-title":"Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial","volume":"48","author":"Stone","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e04369","DOI":"10.1002\/ccr3.4369","article-title":"Granulomatosis with polyangiitis (Wegener\u2019s) complicated by splenic rupture and severe acute respiratory distress syndrome: a case report","volume":"9","author":"Ahmad","year":"2021","journal-title":"Clin Case Reports"},{"key":"ref17","article-title":"Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides","volume":"27","author":"Zhang","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ana.410330103","article-title":"Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic","volume":"33","author":"Nishino","year":"1993","journal-title":"Ann Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","article-title":"ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","volume":"49","author":"Grasselli","year":"2023","journal-title":"Intensive Care Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1001\/jama.2023.24491","article-title":"Prone positioning during extracorporeal membrane oxygenation in patients with severe ARDS: the PRONECMO randomized clinical trial","volume":"330","author":"Schmidt","year":"2023","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fmed.2020.00399","article-title":"False positive COVID-19 antibody test in a case of granulomatosis with polyangiitis","volume":"7","author":"Tzouvelekis","year":"2020","journal-title":"Front Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cmi.2022.10.015","article-title":"Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial","volume":"29","author":"Karampitsakos","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1681\/ASN.2014010046","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement","volume":"26","author":"Geetha","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1461269\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:37:19Z","timestamp":1752154639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1461269\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":26,"alternative-id":["10.3389\/fmed.2025.1461269"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1461269","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1461269"}}